SMN1 Gene Spinal muscular atrophy type 3 Genetic Test
Components: Price 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SMN1 Gene Spinal muscular atrophy type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMN1 Gene Spinal muscular atrophy type 3.
Test Details
Spinal Muscular Atrophy Type 3 (SMA3) is a genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. The SMN1 gene, specifically, is responsible for producing a protein called survival motor neuron (SMN) which is essential for the normal function of motor neurons.
NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing method that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of SMA3, an NGS Genetic Test can be performed to analyze the SMN1 gene and identify any genetic variations or mutations that may be associated with the condition.
The NGS Genetic Test for SMA3 involves obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to analyze the SMN1 gene. The results of the test can help determine whether there are any mutations or variations in the SMN1 gene that may be causing or contributing to the development of SMA3.
This type of genetic testing can be useful for diagnosing SMA3, predicting the risk of developing the condition, and providing information for genetic counseling and family planning. It can also help guide treatment decisions and provide valuable information for ongoing research and development of potential therapies for SMA3.
Test Name | SMN1 Gene Spinal muscular atrophy type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SMN1 Gene Spinal muscular atrophy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SMN1 Gene Spinal muscular atrophy type 3 |
Test Details |
Spinal Muscular Atrophy Type 3 (SMA3) is a genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. The SMN1 gene, specifically, is responsible for producing a protein called survival motor neuron (SMN) which is essential for the normal function of motor neurons. NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing method that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of SMA3, an NGS Genetic Test can be performed to analyze the SMN1 gene and identify any genetic variations or mutations that may be associated with the condition. The NGS Genetic Test for SMA3 involves obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to analyze the SMN1 gene. The results of the test can help determine whether there are any mutations or variations in the SMN1 gene that may be causing or contributing to the development of SMA3. This type of genetic testing can be useful for diagnosing SMA3, predicting the risk of developing the condition, and providing information for genetic counseling and family planning. It can also help guide treatment decisions and provide valuable information for ongoing research and development of potential therapies for SMA3. |